2019 Regular Session
|At the request of:||(at the request of House Interim Committee on Revenue)|
|Bill Title:||Relating to inhalants; prescribing an effective date; providing for revenue raising that requires approval by a three-fifths majority.|
Imposes tax on distribution of inhalant product based on percentage of wholesale sales price.
Defines inhalant product as including inhalant-form nicotine but excluding cigarettes, tobacco products and cannabinoids. Requires licensing of place of business of inhalant product distributor. Establishes licensing program within Department of Revenue. Provides that licensing provisions become operative on January 1, 2020. Establishes civil and criminal penalties. Applies to inhalant product sold on or after January 1, 2020. Takes effect on 91st day following adjournment sine die.
|Fiscal Impact:||Fiscal Impact Issued|
|Revenue Impact:||Revenue Impact Issued|
|Measure Analysis:||Staff Measure Summary / Impact Statements|
|Current Location:||In House Committee|
|Current Committee:||House Committee On Revenue|
|Potential Conflicts of Interest/Vote Explanations:||Potential Conflicts of Interest/Vote Explanation Documents|